Bausch Health Companies | Gastos De Venta Y Administración



Selling And Administration Expenses Cambio Fecha
Amgen USD 1.88B 253M 2024-12
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 850M 18M 2024-09
Biogen USD 677.3M 99.6M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Danaher USD 2.02B 185M 2024-12
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
Novo Nordisk 16.59B 501M 2024-09
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Prestige Brands USD 64.13M 3.35M 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zoetis USD 625M 60M 2024-12



Bausch Health Companies Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.